Hybrid in situ- forming injectable hydrogels for local cancer therapy
- 3 February 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 616, 121534
Abstract
No abstract availableKeywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 114 references indexed in Scilit:
- Injectable and Thermoresponsive Self-Assembled Nanocomposite Hydrogel for Long-Term Anticancer Drug DeliveryLangmuir, 2013
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Fabrication and evaluation of reduction-sensitive supramolecular hydrogel based on cyclodextrin/polymer inclusion for injectable drug-carrier applicationSoft Matter, 2011
- pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxelInternational Journal of Pharmaceutics, 2011
- Thermosensitive in situ-forming dextran–pluronic hydrogels through Michael additionMaterials Science and Engineering: C, 2010
- In Situ Cross-Linkable High Molecular Weight Hyaluronan−Bisphosphonate Conjugate for Localized Delivery and Cell-Specific Targeting: A Hydrogel Linked Prodrug ApproachJournal of the American Chemical Society, 2009
- Thermosensitive hydrogels synthesized by fast Diels–Alder reaction in waterPolymer, 2009
- Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinkingJournal of Controlled Release, 2009
- Hydrolytic Stability of Hydrazones and OximesAngewandte Chemie International Edition, 2008
- A Review of Poloxamer 407 Pharmaceutical and Pharmacological CharacteristicsPharmaceutical Research, 2006